{"id":"https://openalex.org/W2292733117","doi":"https://doi.org/10.1096/fasebj.23.1_supplement.588.1","title":"Current Drug Scheduling Reviews Reported by DEA","display_name":"Current Drug Scheduling Reviews Reported by DEA","publication_year":2009,"publication_date":"2009-04-01","ids":{"openalex":"https://openalex.org/W2292733117","doi":"https://doi.org/10.1096/fasebj.23.1_supplement.588.1","mag":"2292733117"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.23.1_supplement.588.1","doi":"https://doi.org/10.1096/fasebj.23.1_supplement.588.1","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.23.1_supplement.588.1","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030597003","display_name":"Sandy G Ghozland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1323015784","display_name":"Drug Enforcement Administration","ror":"https://ror.org/0568dpm54","country_code":"US","type":"government","lineage":["https://openalex.org/I1314586196","https://openalex.org/I1323015784"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandy G Ghozland","raw_affiliation_strings":["Off. Diversion Control - Drug and Chemical Eval. Section, Drug Enforcement Administration, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Off. Diversion Control - Drug and Chemical Eval. Section, Drug Enforcement Administration, Washington, DC","institution_ids":["https://openalex.org/I1323015784"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054655637","display_name":"Srihari R. Tella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1323015784","display_name":"Drug Enforcement Administration","ror":"https://ror.org/0568dpm54","country_code":"US","type":"government","lineage":["https://openalex.org/I1314586196","https://openalex.org/I1323015784"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srihari R Tella","raw_affiliation_strings":["Off. Diversion Control - Drug and Chemical Eval. Section, Drug Enforcement Administration, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Off. Diversion Control - Drug and Chemical Eval. Section, Drug Enforcement Administration, Washington, DC","institution_ids":["https://openalex.org/I1323015784"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055118119","display_name":"Michelle D. Walker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1323015784","display_name":"Drug Enforcement Administration","ror":"https://ror.org/0568dpm54","country_code":"US","type":"government","lineage":["https://openalex.org/I1314586196","https://openalex.org/I1323015784"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle D Walker","raw_affiliation_strings":["Off. Diversion Control - Drug and Chemical Eval. Section, Drug Enforcement Administration, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Off. Diversion Control - Drug and Chemical Eval. Section, Drug Enforcement Administration, Washington, DC","institution_ids":["https://openalex.org/I1323015784"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Susan M Carr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1323015784","display_name":"Drug Enforcement Administration","ror":"https://ror.org/0568dpm54","country_code":"US","type":"government","lineage":["https://openalex.org/I1314586196","https://openalex.org/I1323015784"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan M Carr","raw_affiliation_strings":["Off. Diversion Control - Drug and Chemical Eval. Section, Drug Enforcement Administration, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Off. Diversion Control - Drug and Chemical Eval. Section, Drug Enforcement Administration, Washington, DC","institution_ids":["https://openalex.org/I1323015784"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018280296","display_name":"Christine A. Sannerud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1323015784","display_name":"Drug Enforcement Administration","ror":"https://ror.org/0568dpm54","country_code":"US","type":"government","lineage":["https://openalex.org/I1314586196","https://openalex.org/I1323015784"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine A Sannerud","raw_affiliation_strings":["Off. Diversion Control - Drug and Chemical Eval. Section, Drug Enforcement Administration, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Off. Diversion Control - Drug and Chemical Eval. Section, Drug Enforcement Administration, Washington, DC","institution_ids":["https://openalex.org/I1323015784"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1323015784"],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.6025000214576721,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.6025000214576721,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.21439999341964722,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.03889999911189079,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/controlled-substances-act","display_name":"Controlled Substances Act","score":0.9290000200271606},{"id":"https://openalex.org/keywords/abuse-potential","display_name":"abuse liability","score":0.7160000205039978},{"id":"https://openalex.org/keywords/hallucinogens","display_name":"hallucinogens","score":0.7039999961853027},{"id":"https://openalex.org/keywords/5-meo-dmt","display_name":"5-MeO-DMT","score":0.875},{"id":"https://openalex.org/keywords/psychotropic-drugs","display_name":"psychotropic drugs","score":0.6330000162124634},{"id":"https://openalex.org/keywords/amineptine","display_name":"amineptine","score":0.9670000076293945},{"id":"https://openalex.org/keywords/brotizolam","display_name":"brotizolam","score":0.9890000224113464},{"id":"https://openalex.org/keywords/carisoprodol","display_name":"carisoprodol","score":0.9779999852180481},{"id":"https://openalex.org/keywords/dextromethorphan","display_name":"dextromethorphan","score":0.9860000014305115},{"id":"https://openalex.org/keywords/salvinorin-a","display_name":"salvinorin A","score":0.9750000238418579},{"id":"https://openalex.org/keywords/nabilone","display_name":"nabilone","score":0.9700000286102295},{"id":"https://openalex.org/keywords/methylphenidate","display_name":"methylphenidate","score":0.8970000147819519},{"id":"https://openalex.org/keywords/cannabis","display_name":"cannabis","score":0.44699999690055847},{"id":"https://openalex.org/keywords/tetrahydrocannabinol","display_name":"tetrahydrocannabinol","score":0.8889999985694885},{"id":"https://openalex.org/keywords/anabolic-androgenic-steroids","display_name":"anabolic steroids","score":0.777999997138977},{"id":"https://openalex.org/keywords/sibutramine","display_name":"sibutramine","score":0.9369999766349792},{"id":"https://openalex.org/keywords/tramadol","display_name":"tramadol","score":0.7730000019073486}],"concepts":[{"id":"https://openalex.org/C2992844032","wikidata":"https://www.wikidata.org/wiki/Q27243428","display_name":"Drug control","level":2,"score":0.5808995962142944},{"id":"https://openalex.org/C124315065","wikidata":"https://www.wikidata.org/wiki/Q194270","display_name":"Hallucinogen","level":2,"score":0.48716065287590027},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46386829018592834},{"id":"https://openalex.org/C2777972796","wikidata":"https://www.wikidata.org/wiki/Q850692","display_name":"Controlled substance","level":3,"score":0.4521288573741913},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3225005865097046},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2621166706085205},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.23.1_supplement.588.1","doi":"https://doi.org/10.1096/fasebj.23.1_supplement.588.1","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.23.1_supplement.588.1","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4301248049","https://openalex.org/W4302611510","https://openalex.org/W4302588761","https://openalex.org/W2935895516","https://openalex.org/W4298439631","https://openalex.org/W7095723525","https://openalex.org/W2402976849","https://openalex.org/W2345966242","https://openalex.org/W4301651515","https://openalex.org/W4302320133"],"abstract_inverted_index":{"Pursuant":[0],"to":[1,127],"the":[2,25,47,94,114,132,138,143,167,173],"Controlled":[3],"Substances":[4],"Act":[5],"(CSA),":[6],"DEA":[7,90,149],"collects":[8],"and":[9,13,40,57,108,123,157],"reviews":[10],"scientific,":[11],"medical":[12],"other":[14],"data":[15,95],"for":[16,21,30,34,96,110,119,134,170],"substances":[17,69,80],"with":[18,142],"abuse":[19],"potential":[20],"possible":[22,111,135],"placement":[23],"under":[24,113,137,172],"CSA.":[26,115,139,174],"The":[27],"administrative":[28],"process":[29],"scheduling":[31],"is":[32,91,150],"ongoing":[33,126],"indiplon,":[35],"carisoprodol,":[36],"dextromethorphan,":[37],"salvinorin":[38],"A":[39],"several":[41,68,97],"petitions":[42],"requesting":[43],"a":[44],"change":[45],"in":[46,87,166],"control":[48,63,66,112,136,171],"status":[49],"of":[50,55,64,67,76],"nabilone,":[51],"methylphenidate":[52],"product,":[53],"removal":[54],"marijuana":[56],"tetrahydrocannabinols":[58],"(THCs)":[59],"from":[60],"schedule":[61,71],"I,":[62],"tramadol,":[65],"as":[70],"III":[72],"anabolic":[73],"steroids,":[74],"decontrol":[75],"sibutramine.":[77],"Numerous":[78],"hallucinogenic":[79],"have":[81],"become":[82],"popular":[83],"among":[84],"drug":[85],"abusers":[86],"recent":[88],"years.":[89],"currently":[92,162],"reviewing":[93,151],"hallucinogens":[98],"including":[99],"5\u2010MeO\u2010DMT,":[100],"5\u2010MeO\u2010AMT,":[101],"5\u2010MeO\u2010DET,":[102],"5\u2010MeO\u2010MIPT,":[103],"DIPT,":[104],"4\u2010OH\u2010DIPT,":[105],"2C\u2010I,":[106],"2C\u2010T\u20102,":[107],"Bromo\u2010dragonfly":[109],"Chemical":[116],"synthesis/pharmacological":[117],"studies":[118],"DOC,":[120],"2C\u2010C,":[121],"2C\u2010D,":[122],"2C\u2010E":[124],"are":[125,160],"determine":[128],"if":[129],"they":[130],"meet":[131],"requirements":[133],"To":[140],"comply":[141],"1971":[144],"Convention":[145],"on":[146],"Psychotropic":[147],"Substances,":[148],"zipeprol,":[152],"amineptine,":[153],"mesocarb,":[154],"4\u2010methylthioamphetamine":[155],"(4\u2010MTA)":[156],"brotizolam,":[158],"which":[159],"not":[161],"controlled":[163],"or":[164],"marketed":[165],"United":[168],"States,":[169]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}